Regulatory Factor X2: Potential Drug Target (G5990)

Target Name: RFX2

NCBI ID: G5990

RFX2

Regulatory Factor X2: Potential Drug Target

Regulatory Factor X2 (RFX2) is a protein that plays a critical role in regulating various cellular processes in the body. It is a key regulator of cell proliferation, differentiation, and survival, and is involved in the development and maintenance of tissues such as blood vessels, neurons, and epithelial cells.

RFX2 is a protein that consists of 219 amino acid residues. It belongs to the T-cell receptor (TCR) family, which is a group of proteins that play a critical role in the development and regulation of T cells, a type of white blood cell that plays a vital role in the immune system.

RFX2 is expressed in many different tissues and cells in the body, including the brain, heart, lungs, kidneys, and intestines. It is also highly expressed in the placenta, which is a vital organ that plays a critical role in the development and growth of fetuses.

RFX2 is involved in many different cellular processes in the body, including cell proliferation, differentiation, and survival. It is a key regulator of the G1/S transition, which is a critical step in the cell cycle that involves the preparation of the cell for cell division.

RFX2 is also involved in the regulation of cell survival. It has been shown to play a critical role in the regulation of cell survival by promoting the expression of the anti-apoptotic protein Bcl-2. Bcl-2 is a protein that has been shown to protect cells from apoptosis, which is the process by which cells die.

RFX2 is also involved in the regulation of cell differentiation. It has been shown to play a critical role in the regulation of stem cell differentiation into functional tissues such as blood vessels, neurons, and epithelial cells.

RFX2 is also involved in the regulation of cell migration. It has been shown to play a critical role in the regulation of cell migration, which is the movement of cells from one location to another in the body.

RFX2 is also involved in the regulation of inflammation. It has been shown to play a critical role in the regulation of inflammation by promoting the production of pro-inflammatory cytokines.

RFX2 is also involved in the regulation of cellular signaling. It has been shown to play a critical role in the regulation of cellular signaling by promoting the interaction between T cells and other cellular signaling pathways.

RFX2 is a protein that plays a critical role in regulating various cellular processes in the body. It is involved in the development and maintenance of tissues such as blood vessels, neurons, and epithelial cells, and is involved in the regulation of cell proliferation, differentiation, and survival. As a result, RFX2 is a potential drug target and may be useful in the development of new treatments for a variety of diseases.

Protein Name: Regulatory Factor X2

Functions: Transcription factor that acts as a key regulator of spermatogenesis. Acts by regulating expression of genes required for the haploid phase during spermiogenesis, such as genes required for cilium assembly and function (By similarity). Recognizes and binds the X-box, a regulatory motif with DNA sequence 5'-GTNRCC(0-3N)RGYAAC-3' present on promoters (PubMed:10330134). Probably activates transcription of the testis-specific histone gene H1-6 (By similarity)

The "RFX2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RFX2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets